The Millennia Software system is indicated for: Cardiac evaluation of heart rate and rhythm in patients experiencing syncope, near syncope, dizziness, palpitations, shortness of breath, chest pain and transient arrhythmia.To assess risk for future cardiac events in patients without symptoms from arrhythmia who have been diagnosed with congestive heart failure, idiopathic hypertrophic cardiomyopathy, and post myocardial infarction with left ventricular dysfunction.Assessment of drug response in patients taking antiarrhythmic medications. Baseline frequency of the arrhythmia should be characterized as reproducible and of sufficient frequency to permit evaluation.ST segment analysis in patients with known coronary heart disease, chest pain, and suspected variant angina.

The Millennia software system is indicated for:Cardiac evaluation of heart rate and rhythm in patients experiencing syncope, near syncope, dizziness, palpitations, shortness of breath, chest pain and transient arrhythmias.To assess risk for future cardiac events in patients without symptoms from arrhythmia who have been diagnosed with congestive heart failure, idiopathic hypertrophic cardiomyopathy, and post myocardial infarction with left ventricular dysfunction.Assessment of drug response in patients taking antiarrhythmic medications. Baseline frequency of the arrhythmia should be characterized as reproducible and of sufficient frequency to permit evaluation.ST segment analysis in patients with known coronary heart disease, chest pain, and suspected variant angina.

The Millennia Software system is indicated for:Cardiac evaluation of heart rate and rhythm in patients experiencing syncope, near syncope, dizziness, palpitations, shortness of breath, chest pain and transient arrhythmias.To assess risk for future cardiac events in patients without symptoms from arrhythmia who have been diagnosed with congestive heart failure, idiopathic hypertrophic cardiomyopathy, and post myocardial infarction with left ventricular dysfunction.Assessment of drug response in patients taking antiarrhythmic medications. Baseline frequency of the arrhythmia should be characterized as reproducible and of sufficient frequency to permit evaluation.ST segment analysis in patients with known coronary heart disease, chest pain, and suspected variant angina.

The Millennia Software system is indicated for:Cardiac evaluation of heart rate and rhythm in patients experiencing syncope, near syncope, dizziness, palpitations, shortness of breath, chest pain and transient arrhythmias.To assess risk for future cardiac events in patients without symptoms from arrhythmia who have been diagnosed with congestive heart failure, idiopathic hypertrophic cardiomyopathy, and post myocardial infarction with left ventricular dysfunction.Assessment of drug response in patients taking antiarrhythmic medications. Baseline frequency of the arrhythmia should be characterized as reproducible and of sufficient frequency to permit evaluation.ST segment analysis in patients with known coronary heart disease, chest pain, and suspected variant angina.

The Millennia Software system is indicated for:Cardiac evaluation of heart rate and rhythm in patients experiencing syncope, near syncope, dizziness, palpitations, shortness of breath, chest pain and transient arrhythmias.To assess risk for future cardiac events in patients without symptoms from arrhythmia who have been diagnosed with congestive heart failure, idiopathic hypertrophic cardiomyopathy, and post myocardial infarction with left ventricular dysfunction.Assessment of drug response in patients taking antiarrhythmic medications. Baseline frequency of the arrhythmia should be characterized as reproducible and of sufficient frequency to permit evaluation.ST segment analysis in patients with known coronary heart disease, chest pain, and suspected variant angina.

The Millennia Software system is indicated for:Cardiac evaluation of heart rate and rhythm in patients experiencing syncope, near syncope, dizziness, palpitations, shortness of breath, chest pain and transient arrhythmias.To assess risk for future cardiac events in patients without symptoms from arrhythmia who have been diagnosed with congestive heart failure, idiopathic hypertrophic cardiomyopathy, and post myocardial infarction with left ventricular dysfunction.Assessment of drug response in patients taking antiarrhythmic medications. Baseline frequency of the arrhythmia should be characterized as reproducible and of sufficient frequency to permit evaluation.ST segment analysis in patients with known coronary heart disease, chest pain, and suspected variant angina.

M12R, 10 Lead patient Cable (AHA)

M12R, 10 Lead patient Cable (DIN)

M12R Holter Recorder

M3R Holter Recorder

M12R Recorder, 7-Lead Cable AHA, System Kit90815187020153; M12R, 7 Lead patient Cable (AHA)90815187020252; M12R Holter Recorder90815187020320; M12R Carrying Case

M12R Recorder, 10-Lead Cable AHA, System Kit90815187020191; M12R, 10 Lead Patient Cable90815187020252; M12R Holter Recorder90815187020320; M12R Carrying Case

M12R, 10 Lead Patient Cable

M12R L Holter Recorder

M12R L Recorder, 10-Lead Cable, AHA, System Kit90815187020184; M12R, 10 Lead patient Cable (DIN)90815187020252; M12R Holter Recorder90815187020320; M12R Carrying Case

5 Lead Patient Cable, IEC, M3R

M3R Intermittent and Continuous ECG Recorder

5-Lead Patient Cable, IEC

M3R L Holter Recorder

M12A Office System Software

M12A Enterprise System Software

HR100 Holter Repair Exchange

HR300 Holter Repair Exchange

HR300 Mini Holter Recorder Repair Exchange

5-Lead Patient Cable, AHA, HR100

7 Lead Patient Cable, AHA, HR100

7 Lead Patient Cable, IEC, HR100

HR100 Carrying Case and Strap

HR300/HR1200/M3R/M12R Carrying Case and Strap

HR100 Battery Cover

HR300/M3R/M12R Battery Cover